Understanding anti-tuberculosis drug efficacy: rethinking bacterial populations and how we model them
about
Non-Invasive Microbial Metabolic Activity Sensing at Single Cell Level by Perfusion of Calcein Acetoxymethyl EsterPharmacokinetic-Pharmacodynamic modelling of intracellular Mycobacterium tuberculosis growth and kill rates is predictive of clinical treatment durationSafety of Resuming Tumor Necrosis Factor Inhibitors in Ankylosing Spondylitis Patients Concomitant with the Treatment of Active Tuberculosis: A Retrospective Nationwide Registry of the Korean Society of Spondyloarthritis Research.A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis.Lessons from black pepper: piperine and derivatives thereof.The long and winding road to inhaled TB therapy: not only the bug's fault.A Macrophage Infection Model to Predict Drug Efficacy Against Mycobacterium Tuberculosis.Current Indications and Outcome of Pulmonary Resections of Tuberculosis Complications in Ibadan,Nigeria.A Novel TetR-Like Transcriptional Regulator Is Induced in Acid-Nitrosative Stress and Controls Expression of an Efflux Pump in Mycobacteria.Ursolic acid and carvacrol may be potential inhibitors of dormancy protein small heat shock protein16.3 of Mycobacterium tuberculosis.Drug targets in dormant Mycobacterium tuberculosis: can the conquest against tuberculosis become a reality?Activity of human beta defensin-1 and its motif against active and dormant Mycobacterium tuberculosis.
P2860
Q27348602-64D808DB-5436-4988-82F3-4B56EF07CC9AQ30377051-6F72E069-F05B-459F-A280-EE454172FAC2Q35996265-0421F617-8507-4F29-BC76-9FADD646DFBBQ36329737-941747D4-12B2-4D08-A434-064D3D18F3C4Q38631441-9D46C052-C56D-43DD-8F0F-D83EC0F1EAE4Q38782463-C9449CBD-AF15-4E66-B86B-319424753DD9Q41529160-98AB5E09-868E-4396-BDE9-3444488B7EAAQ46883002-3896CB5C-B206-4727-B90D-D4F093B217ACQ47112934-30CE8B90-DE18-4883-A126-B514CBCCBE2EQ47687812-17EEAE6C-3821-4898-AC50-8BBE298521E0Q49968014-D206C913-CADC-434C-9A76-950830C0AAF4Q50259871-7FA9F4C7-010C-4246-B5EC-565546FE96E5
P2860
Understanding anti-tuberculosis drug efficacy: rethinking bacterial populations and how we model them
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Understanding anti-tuberculosi ...... ulations and how we model them
@ast
Understanding anti-tuberculosi ...... ulations and how we model them
@en
Understanding anti-tuberculosi ...... ulations and how we model them
@nl
type
label
Understanding anti-tuberculosi ...... ulations and how we model them
@ast
Understanding anti-tuberculosi ...... ulations and how we model them
@en
Understanding anti-tuberculosi ...... ulations and how we model them
@nl
prefLabel
Understanding anti-tuberculosi ...... ulations and how we model them
@ast
Understanding anti-tuberculosi ...... ulations and how we model them
@en
Understanding anti-tuberculosi ...... ulations and how we model them
@nl
P3181
P1476
Understanding anti-tuberculosi ...... ulations and how we model them
@en
P2093
Joana Diniz da Fonseca
P3181
P356
10.1016/J.IJID.2014.11.028
P407
P577
2015-03-01T00:00:00Z